Krystal Biotech Inc.获得FDA平台技术认定,其HSV-1病毒载体用于KB801治疗神经营养性角膜炎。
Krystal Biotech Inc.获得FDA平台技术认定,其HSV-1病毒载体用于KB801治疗神经营养性角膜炎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.